Yi Chen

8.0k total citations · 2 hit papers
151 papers, 5.5k citations indexed

About

Yi Chen is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Yi Chen has authored 151 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 47 papers in Pathology and Forensic Medicine and 46 papers in Oncology. Recurrent topics in Yi Chen's work include Cancer-related Molecular Pathways (24 papers), Tea Polyphenols and Effects (15 papers) and Cancer, Lipids, and Metabolism (13 papers). Yi Chen is often cited by papers focused on Cancer-related Molecular Pathways (24 papers), Tea Polyphenols and Effects (15 papers) and Cancer, Lipids, and Metabolism (13 papers). Yi Chen collaborates with scholars based in China, United States and Australia. Yi Chen's co-authors include Allen Y. Chen, Gary O. Rankin, Yon Rojanasakul, Haitao Luo, Bing‐Hua Jiang, Liying Wang, Warangkana Lohcharoenkal, Ying Gao, Youying Tu and Xingqian Ye and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Yi Chen

146 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention

2012 764 citations Allen Y. Chen, Yi Chen profile →
Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy

2014 468 citations Yi Chen, Yon Rojanasakul et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Chen China	37	2.3k	982	729	695	647	151	5.5k
Katrin Sak India	37	2.8k 1.2×	529 0.5×	729 1.0×	734 1.1×	594 0.9×	125	5.9k
Yu‐Chih Liang Taiwan	44	2.8k 1.2×	1.3k 1.3×	812 1.1×	1.1k 1.5×	676 1.0×	136	6.4k
Jae‐Young Um South Korea	45	3.5k 1.5×	666 0.7×	824 1.1×	495 0.7×	861 1.3×	263	7.5k
Miguel López‐Lázaro Spain	34	2.8k 1.2×	323 0.3×	857 1.2×	733 1.1×	557 0.9×	98	5.8k
Angelika M. Vollmar Germany	56	4.2k 1.8×	599 0.6×	977 1.3×	420 0.6×	924 1.4×	243	9.8k
Han Geuk Seo South Korea	48	3.3k 1.4×	542 0.6×	534 0.7×	449 0.6×	376 0.6×	214	7.1k
Bonglee Kim South Korea	39	2.5k 1.1×	382 0.4×	624 0.9×	329 0.5×	559 0.9×	283	5.3k
Thomas T. Y. Wang United States	37	2.2k 1.0×	891 0.9×	760 1.0×	602 0.9×	532 0.8×	127	4.9k
Simone Reuter United States	23	3.2k 1.4×	379 0.4×	678 0.9×	658 0.9×	770 1.2×	34	7.1k
Jun Sheng China	38	2.2k 0.9×	840 0.9×	1.2k 1.6×	396 0.6×	401 0.6×	241	5.3k

Countries citing papers authored by Yi Chen

Since Specialization

Citations

This map shows the geographic impact of Yi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Chen more than expected).

Fields of papers citing papers by Yi Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Chen. The network helps show where Yi Chen may publish in the future.

Co-authorship network of co-authors of Yi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Chen. A scholar is included among the top collaborators of Yi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Chen. Yi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Ziyi, et al.. (2025). Combined preoperative platelet-albumin ratio and cancer inflammation prognostic index predicts prognosis in colorectal cancer: a retrospective study. Scientific Reports. 15(1). 29500–29500. 1 indexed citations

Zhong, Yu, et al.. (2024). Cryptotanshinone alleviates immunosuppression in endometriosis by targeting MDSCs through JAK2/STAT3 pathway. Phytomedicine. 136. 156227–156227. 1 indexed citations

Huang, Jia, Shihua Zhao, Xiaoming Hu, et al.. (2024). 278P Efficacy and safety of cadonilimab plus lenvatinib in previously immunotherapy treated advanced/metastatic clear cell renal cell carcinoma (ccRCC): A multicenter, single-arm, phase II trial. Annals of Oncology. 35. S1512–S1512. 1 indexed citations

Chen, Yi, et al.. (2024). Dysregulation of c-Jun (JUN) and FBJ murine osteosarcoma viral oncogene homolog B (FOSB) in obese people and their predictive values for metabolic syndrome. Endocrine Journal. 71(12). 1157–1163.

Chen, Yi, et al.. (2024). Transcriptome analysis reveals the mechanism of antifungal peptide epinecidin-1 against Botrytis cinerea by mitochondrial dysfunction and oxidative stress. Pesticide Biochemistry and Physiology. 202. 105932–105932. 7 indexed citations

Zhang, Xu, Yuxiang Wang, Xi Zhang, et al.. (2023). Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors. Signal Transduction and Targeted Therapy. 8(1). 153–153. 6 indexed citations

Li, Meng, et al.. (2022). Prognostic Value of Combining Apelin-12 and Estimated Glomerular Filtration Rate in Patients with ST-Segment Elevation Myocardial Infarction. Journal of Interventional Cardiology. 2022. 1–9. 3 indexed citations

Liu, Wei‐Liang, Yuxuan Chen, Shiang Ning Leaw, et al.. (2022). Lab-scale characterization and semi-field trials of Wolbachia Strain wAlbB in a Taiwan Wolbachia introgressed Ae. aegypti strain. PLoS neglected tropical diseases. 16(1). e0010084–e0010084. 15 indexed citations

Voronkova, Maria A., Rajib Ghosh, Liying W. Rojanasakul, et al.. (2020). SOX2Mediates Carbon Nanotube-Induced Fibrogenesis and Fibroblast Stem Cell Acquisition. ACS Biomaterials Science & Engineering. 6(9). 5290–5304. 8 indexed citations

10.

Liu, Yijun, Zhicheng Wang, Meilin Chen, et al.. (2020). Upregulation of cyclin D1 can act as an independent prognostic marker for longer survival time in human nasopharyngeal carcinoma. Journal of Clinical Laboratory Analysis. 34(8). e23298–e23298. 4 indexed citations

11.

Tu, Youying, Lianfu Chen, Ning Ren, et al.. (2020). Standardized Saponin Extract from Baiye No.1 Tea (Camellia sinensis) Flowers Induced S Phase Cell Cycle Arrest and Apoptosis via AKT-MDM2-p53 Signaling Pathway in Ovarian Cancer Cells. Molecules. 25(15). 3515–3515. 23 indexed citations

12.

Stueckle, Todd A., Rajib Ghosh, Liying W. Rojanasakul, et al.. (2019). Acquisition of cancer stem cell-like properties in human small airway epithelial cells after a long-term exposure to carbon nanomaterials. Environmental Science Nano. 6(7). 2152–2170. 15 indexed citations

13.

Zhang, Yu, Shiguo Chen, Chaoyang Wei, et al.. (2017). Dietary compound proanthocyanidins from Chinese bayberry (Myrica rubra Sieb. et Zucc.) leaves inhibit angiogenesis and regulate cell cycle of cisplatin-resistant ovarian cancer cells via targeting Akt pathway. Journal of Functional Foods. 40. 573–581. 39 indexed citations

14.

Butzkueven, Helmut, Ludwig Kappos, María Trojano, et al.. (2016). Real-World Safety and Efficacy of Natalizumab after Switching from Other Disease-Modifying Therapies (DMTs): Data from the Tysabri® Observational Program (TOP) (P2.069). Neurology. 86(16_supplement). 2 indexed citations

15.

Tu, Youying, Eunhye Kim, Ying Gao, et al.. (2016). Theaflavin-3, 3′-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells. International Journal of Oncology. 48(6). 2657–2665. 45 indexed citations

16.

Huang, Haizhi, Allen Y. Chen, Yon Rojanasakul, et al.. (2015). Dietary compounds galangin and myricetin suppress ovarian cancer cell angiogenesis. Journal of Functional Foods. 15. 464–475. 108 indexed citations

17.

Lau, Jamie K., Kathleen C. Brown, Theodore R. Witte, et al.. (2012). Inhibition of Cholinergic Signaling Causes Apoptosis in Human Bronchioalveolar Carcinoma. Cancer Research. 73(4). 1328–1339. 30 indexed citations

18.

Luo, Haitao, et al.. (2011). Prolonged incubation and stacked film exposure improve sensitivity in western blotting. Journal of Pharmacological and Toxicological Methods. 64(3). 233–237. 8 indexed citations

19.

Luo, Haitao, Bing‐Hua Jiang, Sarah M. King, & Yi Chen. (2008). Inhibition of Cell Growth and VEGF Expression in Ovarian Cancer Cells by Flavonoids. Nutrition and Cancer. 60(6). 800–809. 200 indexed citations

20.

Jones, Douglas B., Kristopher L. Giles, Yi Chen, & Kevin A. Shufran. (2005). Estimation of Hymenopteran Parasitism in Cereal Aphids by Using Molecular Markers. Journal of Economic Entomology. 98(1). 217–221. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact